Arginine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00125 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 16 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gastroparesis (disease) | KG + DL |
| 2 | congenital prothrombin deficiency | KG + DL |
| 3 | dyspepsia | KG + DL |
| 4 | vitamin deficiency disorder | KG + DL |
| 5 | sclerosing cholangitis | KG + DL |
| 6 | obsolete vitamin D deficiency | KG + DL |
| 7 | biotin metabolic disease | KG + DL |
| 8 | hypophosphatemic rickets | KG + DL |
| 9 | postgastrectomy syndrome | KG + DL |
| 10 | non-syndromic esophageal malformation | KG + DL |
| 11 | familial isolated hypoparathyroidism due to impaired PTH secretion | KG + DL |
| 12 | stomach disease | KG + DL |
| 13 | acromesomelic dysplasia, Campailla Martinelli type | KG + DL |
| 14 | Dahlberg-Borer-Newcomer syndrome | KG + DL |
| 15 | craniofacial conodysplasia | KG + DL |
| 16 | urinary tract infection (disease) | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.